Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only.
- Positions
- 13
- No filing for Q3 2024
- Portfolio value
- $258.0M
- No filing for Q3 2024
Merck & Co., Inc. did not file a 13F for Q3 2024, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | Stock | 2,308,190 | $96.0M | 37.2% | – | – | History |
| PSNLPersonalis, Inc. | COM | 14,044,943 | $81.2M | 31.5% | – | – | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $31.1M | 12.0% | – | – | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $30.1M | 11.7% | – | – | – |
| ALECAlector, Inc. | COM | 3,545,719 | $6.70M | 2.6% | – | – | History |
| STROSutro Biopharma, Inc. | COM | 2,723,509 | $5.01M | 1.9% | – | – | History |
| ABSIAbsci Corp | COM | 998,163 | $2.62M | 1.0% | – | – | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $1.79M | 0.7% | – | – | History |
| XLOXilio Therapeutics, Inc. | COM | 1,483,758 | $1.42M | 0.5% | – | – | History |
| LVTXLAVA Therapeutics NV | SHS | 1,149,345 | $1.09M | 0.4% | – | – | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $617.0K | 0.2% | – | – | History |
| EVAXEvaxion A/S | COM | 542,279 | $458.4K | 0.2% | – | – | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $34.4K | <0.1% | – | – | History |